Benzamide, N-hydroxy-4-[(8-quinolinylamino)methyl]-;MPT0G211, 10 mM in DMSO
标准英文名
N-hydroxy-4-((quinolin-8-ylamino)methyl)benzamide
MDL No.
MFCD32063565
分子式
C17H15N3O2
分子量
293.33
精确分子量
293.12
SMILES
O=C(NO)C1=CC=C(CNC2=C3N=CC=CC3=CC=C2)C=C1
标准SMILES
ONC(=O)C1C=CC(CNC2C=CC=C3C=CC=NC3=2)=CC=1
用途
MPT0G211 is a potent, orally active, and selective HDAC6 inhibitor (IC50 = 0.291 nM) with >1000-fold selectivity over other HDAC isoforms; it crosses the blood-brain barrier and ameliorates tau hyperphosphorylation and cognitive deficits in Alzheimer’s disease models; exhibits anti-metastatic and neuroprotective effects; demonstrates anticancer activity.